Cytokine factors present in dengue patient sera induces alterations of junctional proteins in human endothelial cells

American Journal of Tropical Medicine and Hygiene

Volumn 87, Issue 5, 2012, Pages 936-942

  Appanna, Ramapraba ^a   Wang, Seok Mui ^b   Ponnampalavanar, Sasheela A ^a   Lum, Lucy Chai See ^a   Sekaran, Shamala Devi ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; GROWTH FACTOR; RECOMBINANT CYTOKINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LABORATORY TEST; MALAYSIA; MALE; NONHUMAN; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; CYTOKINES; DENGUE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS;

EID: 84869100034     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0606     Document Type: Article

References (23)

1. International Vaccine Institute, 2008. The Pediatric Dengue Vaccine Initiative. Vaccines, Children and a Better World Annual Report. Seoul: International Vaccine Institute, 28-35.
2. World Health Organization, 2009. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization, 3-54.
3. Nielsen DG, 2009. The relationship of interacting immunological components in dengue pathogenesis. J Virol 6: 211.
4. Singhasivanon P, Jacobson J, 2009. Dengue is a major global health problem. J Clin Virol 46: S1-S2.
5. Halstead SB, 2007. Dengue. Lancet 370: 1644-1652. (Pubitemid 350052290)
6. Martina BE, Koraka P, Osterhaus AD, 2009. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564-581.
7. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH, Green S, Ennis FA, Rothman AL, 2007. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. J Virol 1: 1592-1600. (Pubitemid 46214434)
8. Basu A, Chaturvedi UC, 2008. Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol Med Microbiol 53: 287-299.
9. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH, Green S, Ennis FA, Rothman AL, 2007. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. J Virol 1: 1592-1600. (Pubitemid 46214434)
10. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS, 2000. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28: 183-188. (Pubitemid 32939398)
11. Wang SM, Sekaran SD, 2010. Early diagnosis of dengue infection using a commercial dengue duo rapid test kit for the detection of NS1, IgM, IgG. Am J Trop Med Hyg 83: 690-695.
12. World Medical Association Declaration of Helsinki, 2000. Ethical principles for medical research involving human subjects. JAMA 24: 3043-3045.
13. Rothman AL, Ennis FA, 1999. Immunopathogenesis of dengue hemorrhagic fever. Virology 257: 1-6. (Pubitemid 29391794)
14. Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, JairungsriA, Khemnu N, Tangthawornchaikul N, Chotiyarnwong P, Sae-Jang K, Koch M, Jones Y, McMichael A, Xu X, Malasit P, Screaton G, 2006. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J Immunol 176: 3821-3829. (Pubitemid 43364031)
15. Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS, 2000. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol 28: 183-188. (Pubitemid 32939398)
16. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC, 2001. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 30: 229-233. (Pubitemid 32373298)
17. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S, Mokashi N, Vaidva D, Shah PS, Cecelia D, 2010. Clinical findings and pro-inflammatory cytokines in dengue patients in western India: a facility-based study. PLoS ONE 5: e8709.
18. Shresta S, 2012. Role of complement in dengue virus infection: protection or pathogenesis. mBio 3: e00003-12.
19. Kanlaya R, Pattanakitsakul S, Sinchaikul S, Chen ST, ThongboonkerdV, 2009. Alterations in actin cytoskeletal assembly and junctional protein complexes in human endothelial cells induced by dengue virus infection and mimicry of leukocyte transendothelialmigration. J ProteomeRes 8: 2551-2562.
20. Crone C, 1986. Modulation of solute permeability in microvascular endothelium. Fed Proc 45: 77-83. (Pubitemid 16037855)
21. Tseng CS, Lo HW, Teng HC, Lo WC, Ker CG, 2005. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 43: 99-102.
22. Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM, 2000. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg 63: 71-75.
23. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M, 1998. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 161: 6338-6346. (Pubitemid 28536010)